Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?

Fertility and Sterility

Volumn 89, Issue 1, 2008, Pages 151-156

  Schoolcraft, William B ^a   Surrey, Eric S ^a   Minjarez, Debra A ^a   Stevens, John M ^a   Gardner, David K ^a  

^a National Foundation for Fertility Research   (United States)

Author keywords

GnRH agonist; GnRH antagonist; in vitro fertilization; letrozole; ovarian stimulation; poor responder

Indexed keywords

CETRORELIX; GANIRELIX; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OOCYTE MATURATION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AROMATASE INHIBITORS; CHORIONIC GONADOTROPIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EMBRYO CULTURE TECHNIQUES; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; LEUPROLIDE; NITRILES; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME; TRIAZOLES;

EID: 38049188173     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.02.013     Document Type: Article

References (36)

1. Surrey E., and Schoolcraft W. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive technologies. Fertil Steril 73 (2000) 667-676
2. Scott R., and Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonists during ovulation induction for in vitro fertilization. Fertil Steril 61 (1994) 880-885
3. Schoolcraft W., Schlenker T., Gee M., Stevens J., and Wagley L. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle stimulating hormone flare, growth hormone protocol. Fertil Steril 67 (1997) 93-97
4. Surrey E., Bower J., Hill D., Ramsey J., and Surrey M. Clinical and endocrine effects of a microdose GnRH agonist flare regime administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 69 (1998) 419-424
5. Detti L., Williams D., Robins J., Maxwell R., and Thomas M. A comparison of three down regulation approaches for poor responders undergoing in vitro fertilization. Fertil Steril 84 (2005) 1401-1405
6. Craft I., Gorgy A., Hill J., Menon D., and Podsiadly B. Will GnRH antagonists provide new hope for patients considered "difficult responders" to GnRH agonist protocols?. Hum Reprod 14 (1999) 2959-2962
7. Copperman A. Antagonists in poor-responder patients. Fertil Steril 80 Suppl 1 (2003) S16-S24
8. Akman M., Erden H., Tosun S., Bayazit N., Aksoy E., and Bahceci M. Addition of GnRH antagonists in cycles of poor responders undergoing IVF. Hum Reprod 15 (2000) 2145-2147
9. Malmusi S., La Marca A., Giulini S., Xella S., Tagliasacchi D., Marsella T., et al. Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation. Fertil Steril 84 (2005) 402-406
10. Fasouliotis S., Laufer N., Sabbagh-Ehrlich S., Lewin A., Hurwitz A., and Simon A. Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF. J Assist Reprod Genet 20 (2003) 455-460
11. Schmidt D., Brenner T., Orris J., Maier D., Benadiva C., and Nielsen J. A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders. Fertil Steril 83 (2005) 1568-1571
12. Mohamed K., Davies W., Alsopp J., and Lashen H. Agonist "flare-up" versus antagonist in the management of poor responders undergoing in vitro fertilization treatment. Fertil Steril 83 (2005) 331-335
13. Chiang L., Lam P., Lok I., Chiu T., Yeung S., Tjer C., et al. GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial. Hum Reprod 20 (2005) 616-621
14. Mitwally M., and Casper R. Using aromatase inhibitors to induce ovulation in breast Ca survivors. Contemp Ob Gyn 49 (2004) 73-84
15. Mitwally M., and Casper R. Aromatase inhibition improves ovarian response to follicle stimulation hormone in poor responders. Fertil Steril 77 (2002) 776-780
16. Healy S., Tan S., Tulandi T., and Biljan M. Effects of letrozole on superovulation in women undergoing intrauterine insemination. Fertil Steril 80 (2003) 1325-1329
17. Gardner D., Schoolcraft W., Wagley L., Schlenker T., Stevens J., and Hesla J. A prospective randomized trial of blastocyst culture and transfer in in vitro fertilization. Hum Reprod 13 (1998) 3434-3440
18. Schoolcraft W., Surrey E., and Gardner D. Embryo transfer: techniques and variables affecting success. Fertil Steril 76 (2001) 863-870
19. Sharara F., and Scott R. Assessment of ovarian reserve and treatment of low responders. Reprod Med Clin NA 8 (1997) 501-522
20. Scott R., and Hofman G. Prognostic assessment of ovarian reserve. Fertil Steril 63 (1995) 1-11
21. Chang M., Chiang C., Hsieh T., Soong Y., and Hsu K. Use of the antral follicle count to predict the outcome of the assisted reproductive technologies. Fertil Steril 69 (1998) 505-510
22. San Roman G., Surrey E., Judd H., and Kerin J. A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization. Fertil Steril 58 (1992) 744-749
23. Gelety T., Pearlstone A., and Surrey E. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, mid luteal or late luteal phase in normally cycling women. Fertil Steril 64 (1995) 1074-1080
24. Akman M., Erden H., Tosun S., Bayazit N., Aksoy E., and Bahceci M. Comparison of agonistic flare-up protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 16 (2001) 868-870
25. Takahashi K., Mukaida T., Tomiyama T., Goto T., and Oka C. GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures in IVF/ICSI-ET with a GnRH agonist protocol. J Assist Reprod Genet 21 (2004) 317-322
26. D'Amato G., Caroppo E., Pasquadibisaglie A., Carone D., Vitti A., and Vizziello G. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulation hormone and clomiphene citrate for poor responders and women over 35 years. Fertil Steril 81 (2004) 1572-1577
27. Gonen Y., and Casper R. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 5 (1990) 670-674
28. Wramsby H., Fredga K., and Liedholm P. Chromosome analysis of human oocytes removed from preovulatory follicles in stimulated cycles. N Engl J Med 316 (1987) 121-124
29. Mitwally M., and Casper R. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 75 (2001) 305-309
30. Garcia-Velasco J., Moreno L., Pacheco A., Guillén A., Duque L., Requena A., et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 84 (2005) 82-87
31. Jonard S., and Dewailly D. The follicular excess in polycystic ovaries due to intraovarian hyperandrogenism may be the main culprit for the follicular arrest. Hum Reprod Update 10 (2004) 107-117
32. Cedrin-Durnerin, Bulwa S., Hervé F., Martin-Pont B., Uzan M., and Hugues J. The hormonal flare-up following gonadotropin-releasing hormone administration is influenced by a progestagen pretreatment. Hum Reprod 9 (1996) 1859-1863
33. Gonen Y., Jacobsen W., and Casper R. Gonadotropin suppression with oral contraceptives before in vitro fertilization. Fertil Steril 53 (1990) 282-287
34. Dragesic K., Davis O., Fasouliotis S., and Rosenwaks Z. Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders. Fertil Steril 84 (2005) 1023-1026
35. Biljan M., Hemmings R., and Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril 84 Suppl 1 (2005) S95 (abstract)
36. Tulandi T., Martin J., Al-Fadhli R., Kabli N., Forman R., Hitkari J., et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 85 (2006) 1761-1765